Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.

Rainer Vormittag(Vienna General Hospital), Ingrid Pabinger(Medical University of Vienna), Thomas Vukovich(Ludwig Boltzmann Institute Applied Diagnostics), Verena Schönauer, Mirko Hirschl(Hanusch Hospital), Christine Mannhalter(Medical University of Vienna), Erich Minar(Medical University of Vienna), Christine Bialonczyk(Wilhelminen Hospital)
PubMed
November 1, 2005
Cited by 21

Related Papers

Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
|New England Journal of Medicine|2006|1.2k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length
|Circulation|2007|515
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
|Circulation|2007|500